- Price
- $61.22
- Day
- +2.49%
- Mkt Cap
- $5.82B
- 52W Range
- $48.26 – $75.66
- Volume
- 1.10M
- Beta
- 0.81
Find a company by name or ticker and open its page
Breaking news, press releases, and analyst updates.
Most recent articles and analysis covering this company.
Innovation Passport award designed to support accelerated time to market and help expedite patient access to potentially transformative new investigational medicines
Read full article
Dolby's discounted valuation and $756 million cash balance support its long-term case as premium formats and auto licensing expand.
Read full article
Dolby targets a sharp fiscal Q4 rebound as content deals, auto Atmos growth and licensing gains face contract-timing volatility.
Read full article
Dolby beat on earnings but missed on sales last night. Both earnings and sales declined year over year -- but should improve in Q4.
Read full article
Dolby Laboratories NYSE: DLB reported third-quarter fiscal 2026 revenue of $305 million, within its prior guidance range, as strength in Dolby Atmos, Dolby Vision and imaging patents was partly offset by deal timing and foundational audio revenue.
Read full article
DLB beat Q3 earnings estimates despite lower revenue, then forecast strong Q4 growth backed by video licensing, autos and new device categories.
Read full article
For the second quarter of 2026, Aristotle Capital's Global Equity WM Composite posted a total return of 6.92% pure gross of fees (6.40% net of fees), underperforming the MSCI ACWI Index, which returned 14.93%, and the MSCI World Index, which returned 13.76%. During the quarter, we sold our positions in Danaher, Dolby Laboratories, and Tokyo Century and purchased Techtronic Industries and Wal-Mart de Mexico. Munich Re, the world's largest reinsurance company, was a detractor during the quarter.
Read full article
Dolby Laboratories, Inc. (DLB) Q3 2026 Earnings Call Transcript
Read full article
SAN FRANCISCO, July 30, 2026 /PRNewswire/ -- Dolby Laboratories, Inc. (NYSE:DLB) today announced the company's financial results for the third quarter of fiscal 2026. "We continue to execute against our full-year objectives, and we are building momentum across several of our key growth areas," said Kevin Yeaman, President and CEO, Dolby Laboratories.
Read full article
Although the revenue and EPS for Dolby Laboratories (DLB) give a sense of how its business performed in the quarter ended June 2026, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Read full article
Dolby Laboratories (DLB) came out with quarterly earnings of $0.69 per share, beating the Zacks Consensus Estimate of $0.67 per share. This compares to earnings of $0.78 per share a year ago.
Read full article
Dolby Laboratories is now undervalued after a 50%+ decline from its all-time high, trading at 18.7x FCF and 19.7x earnings. DLB's revenue growth remains choppy, but licensing—especially in Broadcast and Mobile—drives solid results and offers mid-single-digit growth potential. Expansion into automotive and increased adoption of Dolby Atmos/Vision by major platforms and automakers support future growth, with modest price increases feasible.
Read full article